Document Detail


Postnatal thyroid hormones for respiratory distress syndrome in preterm infants.
MedLine Citation:
PMID:  17253569     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Preterm infants with respiratory distress syndrome are at increased risk of adverse neonatal and developmental outcomes. In animal research, thyroid hormones stimulate surfactant production and reduce the incidence and severity of respiratory distress when given antenatally.
OBJECTIVES: To determine whether thyroid hormone therapy used postnatally in preterm infants with suspected respiratory distress syndrome results in clinically important improvements in respiratory morbidity and subsequent improvements in neonatal and long term outcomes.
SEARCH STRATEGY: Searches were performed of The Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 1, 2006), MEDLINE (1966 - March 2006), PREMEDLINE (March 2006), EMBASE (1980 - March 2006), previous reviews including cross references, abstracts and conference proceedings, supplemented by requests to expert informants.
SELECTION CRITERIA: Trials that enrolled preterm infants with suspected respiratory distress syndrome and allocated infants thyroid hormone treatment compared to control commenced in the first 48 hours after birth.
DATA COLLECTION AND ANALYSIS: Independent assessment of trial quality and data extraction by each author. Synthesis of data using relative risk (RR) and weighted mean difference (WMD) using standard methods of the Cochrane Collaboration and its Neonatal Review Group.
MAIN RESULTS: Two studies enrolled preterm infants with respiratory distress. Amato (1988) allocated infants to L-thyroxine 50 mug/dose at 1 and at 24 hours or no treatment. Amato (1989) allocated infants to L-triiodothyronine 50 mug/day in two divided doses for two days or no treatment. Both studies had methodological concerns including quasi-random methods of patient allocation, no blinding of treatment or measurement and substantial post allocation losses. Neither study reported any significant benefits in neonatal morbidity or mortality from use of thyroid hormones. Meta-analysis of two studies (80 infants) found no significant difference in mortality to discharge (typical RR 1.00, 95% CI 0.47, 2.14). Amato 1988 reported no significant difference in use of mechanical ventilation (RR 0.64, 95% CI 0.38, 1.09). No significant effects were found in use of mechanical ventilation, duration of mechanical ventilation, air leak, CLD at 28 days in survivors, patent ductus arteriosus, intraventricular haemorrhage or necrotising enterocolitis. Neurodevelopment was not reported.
AUTHORS' CONCLUSIONS: There is no evidence from controlled clinical trials that postnatal thyroid hormone treatment reduces the severity of respiratory distress syndrome, neonatal morbidity or mortality in preterm infants with respiratory distress syndrome.
Authors:
D A Osborn; R W Hunt
Related Documents :
22729659 - Breastfeeding duration, social and occupational characteristics of mothers in the frenc...
1735849 - Controlled trial of a single dose of synthetic surfactant at birth in premature infants...
23432339 - Pharmacokinetics of melatonin in preterm infants.
23921419 - Resuscitation intensity at birth is associated with changes in brain metabolic developm...
7123489 - One-stage resection for massive cervicomediastinal hygroma.
12051649 - Naphthalene, phenanthrene and surfactant biodegradation.
22954269 - Control of oxygenation during mechanical ventilation in the premature infant.
11309829 - Leukodepletion for acute lymphocytic leukemia in a three-week-old infant.
6772879 - Vital statistics from a laboratory breeding colony of squirrel monkeys (saimiri sciureus).
Publication Detail:
Type:  Journal Article; Meta-Analysis; Review     Date:  2007-01-24
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  -     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2007  
Date Detail:
Created Date:  2007-01-26     Completed Date:  2007-05-08     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD005946     Citation Subset:  IM    
Affiliation:
Royal Prince Alfred Hospital, RPA Newborn Care, Missenden Road, Camperdown, New South Wales, Australia, 2050. david.osborn@email.cs.nsw.gov.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Infant, Newborn
Infant, Premature
Respiratory Distress Syndrome, Newborn / drug therapy*
Thyroid Hormones / therapeutic use*
Thyroxine / therapeutic use
Triiodothyronine / therapeutic use
Chemical
Reg. No./Substance:
0/Thyroid Hormones; 6893-02-3/Triiodothyronine; 7488-70-2/Thyroxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia.
Next Document:  Glutamine supplementation for young infants with severe gastrointestinal disease.